Thomas Dayspring: Reshaping the Biology of Atherosclerotic Plaques with New Therapies
Thomas Dayspring, Lipid Specialist, Educator at Early Medical, shared Atherosclerosis‘s post on LinkedIn, adding:
“A fantastic read worthy of a download – authors conclusion: ‘The future of atherothrombosis management lies in early detection, integrated targeting of multiple pathogenic pathways, and individualized patient care.'”
Atherosclerosis shared a post on LinkedIn about a recent article by L. Badimon et. al, adding:
“Could atherosclerosis become a chronic, controlled disease rather than a rupture-prone condition?
Intensive lipid lowering does more than reduce cardiovascular risk.
It can change plaque composition, promote stabilization, and in some cases induce regression.
At the same time, emerging anti-inflammatory therapies are beginning to address the residual risk that persists even after LDL cholesterol has been lowered.
The challenge now is identifying the right biological target for the right patient.
Could targeting lipids and inflammation together redefine the natural history of atherothrombosis?
Curious to explore how new therapies are reshaping the biology of atherosclerotic plaques?”
Title: A new era in atherothrombosis
Authors: L. Badimona, G. Vilahurb, G. Mendieta
Stay updated with Hemostasis Today.
-
Nov 9, 2026, 13:48PF4-ELISA–Negative HIT: Are We Missing a New Class of Anti-PF4 Immunothrombotic Disease?
-
Nov 9, 2026, 13:07Nandini Sadasivam: Gene Therapy for Sickle Cell Disease and Thalassaemia
-
Nov 9, 2026, 13:04Raising Awareness of Bleeding Disorders in Women and Girls – EHC
-
Nov 9, 2026, 12:59Rahul Bohra: Exploring the Complex Mechanisms of Sickle Cell Disease
-
Nov 9, 2026, 12:53Three Years of Movement and Thrombosis Awareness in the Czech Republic – World Thrombosis day
-
Nov 9, 2026, 12:51Octavio Marques Pontes-Neto: Intensive Blood-Pressure Control Reduces Cardiovascular Events After Ischemic Stroke
-
Nov 9, 2026, 12:49Irma Bagdoniene: What Really Makes Us Live Longer
-
Nov 9, 2026, 12:47Imo Akpan: Announcing the 2027 Women’s Hematology Summit
-
Nov 9, 2026, 12:45Shadi Yaghi: Rethinking Antithrombotic Therapy After Stroke